Organization and Personnel Changes

February 26,2021
J-Pharma Co., Ltd.

PDF For Print

Yokohama, Japan, February 26, 2021 – J-Pharma Co., Ltd. (“J-Pharma”) has announced the below organization and personnel changes upon the approval of extraordinary meeting of shareholders on February 25, 2020.

1.Transition to a company with board of company auditors

2.Changes of Board Members

① New Board Members

Title Name Current Position
External Director Sadashi Suzuki Representative, Newton Biocapital Partners, Japan
External Director Shinichiro Komoto Partner, Eight-Roads Ventures Japan

② New Auditors

Title Name Current Position
Audit & Supervisory
Board Member
Tadashi Takeuchi Small and Medium Enterprise Management Consultant
Audit & Supervisory
Board Member
Teruhisa Tajima Certified Public Accountant
Representative, Tajima CPA firm
Audit & Supervisory
Board Member
Toshio Furuta Lawyer
Representative, Clair Law firm

③ Retired Audit & Supervisory Board Member

Name
Yukou Ikuta
Futoshi Nakamura

【Reference】
All the Board Members as of February 26

Title Name Current Position
Chief Executive Officer Masuhiro Yoshitake ―
Director, Corporate Planning Yoshinori Bamba ―
Director, R&D Takehiro Igawa ―
External Director Satoe Otsubo Director, Venture Investment Team

Shinsei Corporate Investment

External Director Sadashi Suzuki Representative, Newton Biocapital Partners, Japan
External Director Shinichiro Komoto Eight-Roads Ventures Japan
External Director Toshiyuki Mori Representative, TM Partners
Audit & Supervisory Board Member Tadashi Takeuchi Small and Medium Enterprise Management Consultant
Audit & Supervisory Board Member Teruhisa Tajima Certified Public Accountant
Representative, Tajima CPA firm
Audit & Supervisory Board Member Toshio Furuta Lawyer
Representative, Clair Law firm

Contact: Tomohiro Yuzawa, Director,
Corporate Management Dept.
Tel: 045-506-1155
info@j-pharma.com